BRIEF published on 10/06/2025 at 14:56, 8 months 18 days ago Threshold Crossing by Bpifrance at ABIONYX PHARMA Voting Rights Actions Threshold Crossing Bpifrance ABIONYX Pharma
PRESS RELEASE published on 10/06/2025 at 14:55, 8 months 18 days ago Franchissement de seuil Déclaration de franchissement de seuil pour ABIONYX PHARMA par la Caisse des dépôts et consignations via Bpifrance Participations Déclaration Franchissement De Seuil Bpifrance Caisse Des Dépôts ABIONYX Pharma
PRESS RELEASE published on 10/06/2025 at 14:51, 8 months 18 days ago Franchissement de seuil Déclaration de franchissement de seuil par Bpifrance concernant ABIONYX PHARMA sur Euronext Paris, le 29 septembre 2025 Euronext Paris Franchissement De Seuil Bpifrance ABIONYX Pharma 29 Septembre 2025
BRIEF published on 09/25/2025 at 20:21, 8 months 28 days ago ABIONYX Pharma : Résultats financiers du premier semestre 2025 Résultats Financiers Recherche Et Développement Trésorerie Plan France 2030 ABIONYX Pharma
BRIEF published on 09/25/2025 at 20:21, 8 months 28 days ago ABIONYX Pharma: Financial results for the first half of 2025 Financial Results Research And Development Treasury France 2030 Plan ABIONYX Pharma
PRESS RELEASE published on 09/25/2025 at 20:16, 8 months 28 days ago Informations privilégiées / Communiqué sur comptes, résultats ABIONYX Pharma annonce ses résultats financiers du 1er semestre 2025. Chiffre d'affaires de 2,1 M€, pertes réduites. Trésorerie à 3,4 M€. Lauréat du plan France 2030 Chiffre D'affaires Résultats Financiers Trésorerie ABIONYX Pharma 1er Semestre 2025
PRESS RELEASE published on 09/25/2025 at 20:16, 8 months 28 days ago Inside Information / News release on accounts, results ABIONYX Pharma announces its 2025 half-year financial results, including revenue of €2.1 million and ongoing initiatives in biotech innovation. Company receives government support for sepsis research Revenue Biotech Innovation ABIONYX Pharma 2025 Financial Results Sepsis Research
PRESS RELEASE published on 09/25/2025 at 18:58, 8 months 28 days ago Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel
BRIEF published on 08/28/2025 at 18:56, 9 months 26 days ago Bilan semestriel 2025 d'ABIONYX Pharma Chiffre D'affaires Trésorerie ABIONYX Pharma Soutien Financier Semestre 2025
BRIEF published on 08/28/2025 at 18:56, 9 months 26 days ago ABIONYX Pharma 2025 half-year review Treasury Financial Support Turnover ABIONYX Pharma Semester 2025
Published on 06/24/2026 at 14:45, 1 hour 1 minute ago Amdocs Selected by Three Scandinavia to Support Customer Engagement Transformation Across Nordic Markets
Published on 06/24/2026 at 14:00, 1 hour 46 minutes ago GameSquare and U.S. Army Partner for Soldier Showdown 8, Presented by USAA
Published on 06/24/2026 at 14:00, 1 hour 46 minutes ago Adcore Announces Voting Results from Annual Shareholders Meeting
Published on 06/24/2026 at 13:05, 2 hours 41 minutes ago Faraday Copper Reports Drill Results Including Near-Surface Copper Mineralization in the American Eagle Area
Published on 06/24/2026 at 13:00, 2 hours 46 minutes ago Aston Bay Provides Update on the Storm Copper Project - Advancing Towards Development
Published on 06/24/2026 at 15:30, 16 minutes ago Alta Group announcement on Voluntary Takeover Offers for Addiko Bank AG
Published on 06/24/2026 at 15:19, 26 minutes ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 06/24/2026 at 15:18, 27 minutes ago Form 8.3 - The Vanguard Group, Inc.: Forward Industries Inc.
Published on 06/24/2026 at 09:30, 6 hours 16 minutes ago CP HOPENING - Le 1er Baromètre “Libéralités - Grande Transmission”
Published on 06/23/2026 at 19:47, 19 hours 58 minutes ago GROUPE SFPI: reorganisation de la Direction Générale
Published on 06/23/2026 at 19:47, 19 hours 58 minutes ago GROUPE SFPI: General management reorganisation
Published on 06/23/2026 at 19:10, 20 hours 35 minutes ago GUILLEMOT CORPORATION > EVOLUTION DE LA GOUVERNANCE A COMPTER DU 23 JUIN 2026
Published on 06/23/2026 at 19:10, 20 hours 35 minutes ago GUILLEMOT CORPORATION: Changes to Corporate Governance Effective June 23, 2026
